YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
11.13
+0.28 (2.58%)
At close: Feb 4, 2026, 4:00 PM EST
11.13
0.00 (0.00%)
After-hours: Feb 4, 2026, 4:00 PM EST
YD Bio Market Cap
YD Bio has a market cap or net worth of $782.66 million as of February 4, 2026. Its market cap has increased by 1,632.41% in one year.
Market Cap
782.66M
Enterprise Value
763.38M
1-Year Change
1,632.41%
Ranking
Category
Stock Price
$11.13
Market Cap Chart
Since December 23, 2020, YD Bio's market cap has increased from $148.36M to $782.66M, an increase of 427.56%. That is a compound annual growth rate of 38.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 762.97M | -10.99% |
| Dec 31, 2025 | 857.20M | 1,788.97% |
| Dec 26, 2024 | 45.38M | -4.31% |
| Dec 28, 2023 | 47.42M | -5.87% |
| Dec 30, 2022 | 50.38M | -66.30% |
| Dec 31, 2021 | 149.47M | 3.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Maravai LifeSciences Holdings | 863.01M |
| Arbutus Biopharma | 844.30M |
| Janux Therapeutics | 841.47M |
| Omeros | 830.95M |
| KalVista Pharmaceuticals | 814.30M |
| Valneva SE | 799.94M |
| Bright Minds Biosciences | 786.55M |
| MapLight Therapeutics | 782.49M |